Vice President, Strategy, Business Development and New Product Planning
Bipin Dalmia is responsible for all Ferring U.S. strategy, business development, and new product planning activities and is a key member of the Ferring Global Marketing and Business Development group. Bipin has over 25 years of experience in pharmaceuticals and biotechnology industries, starting as a research scientist and transitioning early in his career to licensing and business development. Before joining Ferring in 2012, he held roles of rapidly increasing responsibilities at Biolex Therapeutics, Syngenta and Novartis. During his 20-year business development career, he has led to conclusion over 60 transactions, both on the buy and sell sides, in biotech, specialty pharma and big pharma across several therapeutic areas and development stages. Bipin holds an MBA degree from Drake University in Des Moines, Iowa, and a Ph.D. in Chemical Engineering from Iowa State University in Ames, Iowa.